What We're Reading: Page 13
Industry reads hand-picked by our editors
Jun 20, 2025
Jun 18, 2025
Jun 17, 2025
Jun 16, 2025
-
Fierce Biotech
The trouble with TIGITs: How ‘overenthusiasm’ led to Big Pharma’s risky $6B gamble
-
Axios
NIH chief sidesteps controversy while other officials court it
-
NPR
The doctor said ‘be happy.’ Music therapy can help cancer patients do that
-
Bloomberg
China’s Biotech Moment Ignites a 60% Stock Rally That Beats AI
Jun 13, 2025
-
ProPublica
Shattered Science: The Research Lost as Trump Targets NIH Funding
-
Axios
RFK Jr. blows up America’s vaccine policy
-
The Wall Street Journal
Senators Propose Ban on Drug Advertising to Consumers
Jun 12, 2025
Jun 11, 2025
-
Science
Science’s reform movement should have seen Trump’s call for ‘gold standard science’ coming, critics say
-
Fierce Biotech
Pfizer CEO talks Chinese due diligence, ADC synergies to justify $6B bet on ‘fabulous’ bispecific
-
The Wall Street Journal
These Diabetes Drugs Are Finding New Life as an Antiaging Hack
Previous
